NASDAQ: JAZZ · Biotechnology
Over the past week, Jazz Pharmaceuticals (JAZZ) logged 15 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 61% bullish but is sharply divided: X runs 100% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 18 of 20 analysts rating JAZZ a buy.
There is little buzz around JAZZ this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 90% buy share sits next to a crowd that ranges from Reddit at 0% to X at 100%. No other tracker puts the two side by side.
20 analysts have weighed in: a Strong Buy consensus: 18 buy calls against 0 sell, with an average 12-month price target of $289.45.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 29 points above the crowd average of 61%, the professionals are more constructive than retail. The split is inside the crowd: X reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Jazz Pharmaceuticals (JAZZ) buzz held subdued around 19.8 while the price drifted down 3.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1M shares. Over the last 7 trading days, JAZZ lost 1.7%. Buzz activity in the recent week averaged 36.1 and was variable, swinging between 19.8 and 44.6. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 12 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for JAZZ and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live JAZZ sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (18 / 2 / 0) |
| Crowd bullish (7d) | 61% |
| Avg price target | $289.45 |
| Most bullish source | X, 100% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 15 |
| Market cap | $16.07B |
| P/E · Forward P/E | 16.8 · 11.0 |
| EPS · Beta | $14.73 · 0.4 |
| Revenue (TTM) | $4.6B · 20% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Jazz Pharmaceuticals (JAZZ) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 61% bullish across 3 active sources. Those sources contribute 15 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Jazz Pharmaceuticals (JAZZ) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Jazz Pharmaceuticals (JAZZ), averaging 61% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 100% bullish and Reddit at 0%, a 100-point spread. On the professional side, 18 of 20 analysts rate JAZZ a buy.
Of the 20 analysts covering Jazz Pharmaceuticals (JAZZ), 18 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $289.45. That puts the street ahead of the crowd, which averages 61% bullish.
Jazz Pharmaceuticals (JAZZ)'s cross-source average is bullish at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. X reads 100% bullish, News reads 83% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Jazz Pharmaceuticals (JAZZ) at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across News. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 12 mentions (80% of total volume). X contributes 3 mentions. The cross-source average is bullish at 61% bullish, while news is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. JAZZ's buy signal at 93/100 conviction reflects a bullish cross-source average at 61% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The JAZZ sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key